日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ELK1 inhibition alleviates amyloid pathology and memory decline by promoting the SYVN1-mediated ubiquitination and degradation of PS1 in Alzheimer's disease.

ELK1 抑制通过促进 SYVN1 介导的 PS1 泛素化和降解来减轻阿尔茨海默病中的淀粉样蛋白病理和记忆力衰退

Yi Lilin, Li Junjie, He Yan, Wang Jiaojiao, Wang Maoju, Guo Song, Luo Man, Wu Bin, Xu Mingliang, Tian Qiuyun, Fan Yepeng, Chen Mulan, Xu Boqing, Xia Lei, Song Weihong, He Guiqiong, Du Yehong, Dong Zhifang

Development and validation of immunotherapy nomogram for predicting the efficacy and prognosis of recurrent and metastatic cervical cancer

开发和验证用于预测复发性和转移性宫颈癌疗效和预后的免疫治疗列线图

Liu, Zhongan; Zhang, Sijia; Wang, Yan; Zong, Yan; Zhou, Tian; Wu, Daying; Wang, Ganxin; He, Lihong; Huang, Kai; Xu, Yunqing; Tang, Quan; Chen, Mulan; Xiao, Guangqin; Li, Guiling

GALM Alleviates Aβ Pathology and Cognitive Deficit Through Increasing ADAM10 Maturation in a Mouse Model of Alzheimer's Disease.

GALM 通过增加阿尔茨海默病小鼠模型中 ADAM10 的成熟度来缓解 Aβ 病理和认知缺陷

Tian Na, Li Junjie, Shi Xiuyu, Xu Mingliang, Xiao Qian, Tian Qiuyun, Chen Mulan, Song Weihong, Du Yehong, Dong Zhifang

Accelerating wound healing by biomineralizing crystallization formed from ZIF-8/PLA nanofibers with enhanced revascularization and inflammation reduction

利用ZIF-8/PLA纳米纤维形成的生物矿化结晶加速伤口愈合,增强血管再生并减轻炎症

Wang, Xiangsheng; Zhang, Xueer; Wang, Bingqian; Tan, Zhixiang; Chen, Mulan; Shen, Haiyan; Cheng, Hanxiao; Zhou, Zhentao; Zhu, Zhanyong; Guo, Jing; Zhang, Jufang

Genetic diversity analysis of IVM resistant Haemonchus contortus in sheep in inner Mongolia of China

中国内蒙古绵羊伊维菌素抗性捻转血矛线虫的遗传多样性分析

Zhang, Yanmin; Wen, Haifeng; Zhang, Hao; Liu, Hao; Zhang, Lili; Lu, Jing; Luo, Chagan; Chen, Mulan; Wu, Weijie; Wang, Wenlong; Wang, Yu; Liu, Chunxia

Application and Progress of Antibody-Drug Conjugates (ADCs) in the Treatment of Metastatic Triple-Negative Breast Cancer

抗体药物偶联物(ADCs)在转移性三阴性乳腺癌治疗中的应用及进展

Xie, Banghong; Chen, Chao; Cai, Haolin; Wang, Lili; Chen, Mulan; Liu, Jian; Wu, Fan; Huang, Weiwei

Cost-effectiveness of utidelone and capecitabine versus monotherapy in anthracycline- and taxane-refractory metastatic breast cancer

乌替隆联合卡培他滨与单药治疗蒽环类和紫杉烷类耐药转移性乳腺癌的成本效益分析

Chen, Mulan; Zhang, Heng; He, Xiaoyan; Lin, Yingtao

Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study

艾立布林化疗方案与其他化疗方案治疗转移性三阴性乳腺癌患者的可行性和耐受性:一项单中心回顾性研究

Huang, Weiwei; Wang, Chenxi; Wang, Lili; Shen, Yangkun; Chen, Qi; Huang, Zhijian; Liu, Jian; Lin, Xiaoyan; Wu, Fan; Chen, Xinhua; Li, Nani; Hong, Yi; Chen, Mulan; Li, Jieyu; Huang, Chuanzhong

A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer

一项关于阿帕替尼方案治疗转移性三阴性乳腺癌的有效性和安全性的真实世界研究

Huang, Weiwei; Wang, Chenxi; Shen, Yangkun; Chen, Qi; Huang, Zhijian; Liu, Jian; Lin, Xiaoyan; Wang, Lili; Wu, Fan; Chen, Xinhua; Li, Nani; Hong, Yi; Chen, Mulan; Li, Jieyu; Huang, Chuanzhong

Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer

更正:一项关于阿帕替尼方案治疗转移性三阴性乳腺癌的有效性和安全性的真实世界研究

Huang, Weiwei; Wang, Chenxi; Shen, Yangkun; Chen, Qi; Huang, Zhijian; Liu, Jian; Lin, Xiaoyan; Wang, Lili; Wu, Fan; Chen, Xinhua; Li, Nani; Hong, Yi; Chen, Mulan; Li, Jieyu; Huang, Chuanzhong